Publication | Closed Access
LMDS-1, a potential TrkB receptor agonist provides a safe and neurotrophic effect for early-phase Alzheimer’s disease
17
Citations
65
References
2020
Year
Neurodegenerative DiseasesAlzheimer's DiseaseMedicineNeuropharmacologyEarly-phase Alzheimer ’NeuroprotectionNeurologyNeuroscienceNeurodegenerationMolecular NeurobiologyPharmacologyNeurotrophic EffectProtective Mechanisms
| Year | Citations | |
|---|---|---|
Page 1
Page 1